Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-065380
Filing Date
2011-11-21
Accepted
2011-11-21 12:28:03
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-26151_110q.htm 10-Q 515725
2 EX-31.1 a11-26151_1ex31d1.htm EX-31.1 9772
3 EX-31.2 a11-26151_1ex31d2.htm EX-31.2 9830
4 EX-32.1 a11-26151_1ex32d1.htm EX-32.1 5354
5 EX-32.2 a11-26151_1ex32d2.htm EX-32.2 5744
  Complete submission text file 0001104659-11-065380.txt   1981974

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rpbc-20110930.xml EX-101.INS 195750
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rpbc-20110930.xsd EX-101.SCH 12491
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rpbc-20110930_cal.xml EX-101.CAL 37670
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rpbc-20110930_lab.xml EX-101.LAB 190815
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rpbc-20110930_pre.xml EX-101.PRE 92101
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rpbc-20110930_def.xml EX-101.DEF 61907
Mailing Address 7 GRAPHICS DRIVE EWING NJ 08628
Business Address 7 GRAPHICS DRIVE EWING NJ 08628 609 637-9700
Redpoint Bio CORP (Filer) CIK: 0001328003 (see all company filings)

EIN.: 203215854 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51708 | Film No.: 111218319
SIC: 8731 Services-Commercial Physical & Biological Research